BioNTech confident Covid-19 vaccine effective against new UK mutation
Ugur Sahin, CEO and co-founder of German biotech firm BioNTech, is interviewed by journalists in Marburg, Germany on September 17, 2020. File photo: Reuters/ Fabian Bimmer
BioNTech Chief Executive Ugur Sahin said on Monday he was confident a Covid-19 vaccine co-developed by his company would be effective against a variant of the virus that has emerged in Britain.
He said on Bild TV the company would investigation the mutation in the coming days but that he viewed the matter with "with a degree of soberness".
For all latest news, follow The Daily Star's Google News channel.
Comments